Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT00792441
Other study ID # KKU4950900071
Secondary ID HE501034
Status Active, not recruiting
Phase N/A
First received November 17, 2008
Last updated April 1, 2015
Start date January 2007
Est. completion date December 2015

Study information

Verified date April 2015
Source Khon Kaen University
Contact n/a
Is FDA regulated No
Health authority Thailand: Khon Kaen University Ethics Committee for Human Research
Study type Interventional

Clinical Trial Summary

Prolong mechanical ventilation cause to respiratory muscle weakness and high risk to weaning failure,the investigators hypothesize that

1. Specific inspiratory muscle training (SIMT) using threshold loaded breathing device (BreatheMAX V.1)in patients with ventilator dependence will improve inspiratory muscle strength

2. SIMT will improve lung function in patients with ventilatory dependence.

3. SIMT will improve weaning success in patients with ventilatory dependence.


Description:

Prolonged mechanical ventilation cause detrimental effects on lung function and high risk of lung complications and standard weaning protocols are not successful in a number of patients. The strength of the inspiratory muscles is important factors in the success of weaning. Although, the inspiratory muscles are trained by manipulating the ventilator sensitivity and made of ventilation in the traditional protocol, the muscle function might not improved sufficiently to sustain independent and spontaneous breathing. Consequently, specific inspiratory muscle training is indicated and has been studied in patient with weaning failure. However, there is little evidence available and no firm conclusion can be drown. Therefore, the purpose of this study is to determine whether specific IMT training using the local made loaded threshold IMT device can improve lung function and accelerate the weaning process.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 20
Est. completion date December 2015
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender Both
Age group 30 Years and older
Eligibility Inclusion Criteria:

- Patient who have been mechanically ventilated > 72 hours and start to weaning from medical order or ventilator dependent patients who have failed to wean prior to study.

- Normal arterial blood gas (PaCO2 < 50mmHg, PaO2 > 60 mmHg on FiO2 <0.5 or SaO2 > 90%, PH 7.35-7.45).

- Cardiovascular stability (HR = 140 beats/min, systolic BP 90-140 mmHg and diastolic BP 60-90 mmHg, with no or minimal vasopressors)

- Good consciousness, cooperation and can sit in an upright position > 30 minutes

Exclusion Criteria:

- Persistent homodynamic instability.

- Severe breathlessness at rest when spontaneous breathing.

- Coronary heart disease with angina.

- Life threatening arrhythmia (VF, VT).

- Sedation Ramsay scale > 2

- Severity of disease APACHE II score > 29

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
intervention group
inspiratory muscle training at 50% of peak negative inspiratory muscle training (PNIP)will be performed with 6 breathe/set, 10 set/day, once a day for 28 days.

Locations

Country Name City State
Thailand Respiratory Intensive Care Unit (RICU),Srinagarind Hospital Khon Kaen

Sponsors (2)

Lead Sponsor Collaborator
Saikaew Chuachan Khon Kaen University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peak Negative Inspiratory Pressure (PNIP) every 7 day for 28 days Yes
Secondary Lung compliance every 7 day for 28 days Yes
Secondary Vital capacity every 7 day for 28 days Yes
Secondary Rate perceived breathlessness every 7 day for 28 day Yes
Secondary Airway resistance every 7 day for 28 days. Yes
Secondary Tidal volume every 7 day for 28 days. Yes
Secondary Minute ventilation every 7 day for 28 days. Yes
Secondary End tidal carbondioxide (PetCO2) every 7 day for 28 days. Yes
Secondary SpO2 every 7 day for 28 days. Yes
Secondary Heart rate every 7 day for 28 days. Yes
Secondary Respiratory rate every 7 day for 28 days. Yes
Secondary Weaning success every 7 day for 28 days. Yes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05441657 - Visualizing Regional Lung Ventilation in Patients With Postacute-COVID-19
Recruiting NCT06057714 - Quantitation and Spatial Registration of Airways Dysfunction With Dynamic 19F MRI in Cystic Fibrosis